Agenus, Inc. (AGEN)
6.73
-0.14
(-2.04%)
USD |
NASDAQ |
Nov 13, 16:00
6.72
-0.01
(-0.15%)
After-Hours: 19:59
Agenus EPS Diluted (Quarterly) : 0.0183 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.0183 |
| June 30, 2026 | -0.0146 |
| March 31, 2026 | 1.023 |
| December 31, 2025 | -0.301 |
| September 30, 2025 | 1.944 |
| June 30, 2025 | -0.9962 |
| March 31, 2025 | -1.035 |
| December 31, 2024 | -2.04 |
| September 30, 2024 | -3.083 |
| June 30, 2024 | -2.523 |
| March 31, 2024 | -3.041 |
| December 31, 2023 | -2.350 |
| September 30, 2023 | -3.293 |
| June 30, 2023 | -3.931 |
| March 31, 2023 | -4.308 |
| December 31, 2022 | -4.80 |
| September 30, 2022 | -3.784 |
| June 30, 2022 | -3.356 |
| March 31, 2022 | -3.746 |
| December 31, 2021 | -5.104 |
| September 30, 2021 | 14.47 |
| June 30, 2021 | -7.478 |
| March 31, 2021 | -5.364 |
| December 31, 2020 | -3.841 |
| September 30, 2020 | -5.606 |
| Date | Value |
|---|---|
| June 30, 2020 | -5.621 |
| March 31, 2020 | -6.167 |
| December 31, 2019 | -4.369 |
| September 30, 2019 | -6.616 |
| June 30, 2019 | -7.529 |
| March 31, 2019 | 2.484 |
| December 31, 2018 | -8.00 |
| September 30, 2018 | -5.771 |
| June 30, 2018 | -4.80 |
| March 31, 2018 | -10.60 |
| December 31, 2017 | -7.00 |
| September 30, 2017 | -7.40 |
| June 30, 2017 | -6.40 |
| March 31, 2017 | -3.60 |
| December 31, 2016 | -6.00 |
| September 30, 2016 | -9.40 |
| June 30, 2016 | -6.60 |
| March 31, 2016 | -7.40 |
| December 31, 2015 | -3.60 |
| September 30, 2015 | -3.20 |
| June 30, 2015 | -10.60 |
| March 31, 2015 | -5.60 |
| December 31, 2014 | -8.20 |
| September 30, 2014 | -2.60 |
| June 30, 2014 | -2.40 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 2.015 |
| AVITA Medical, Inc. | -0.2016 |
| Iovance Biotherapeutics, Inc. | -0.0488 |
| Xencor, Inc. | 0.5033 |
| Amgen, Inc. | 7.077 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.567M |
| Revenue (Quarterly) | 31.49M |
| Total Expenses (Quarterly) | 29.91M |
| Enterprise Value | 487.93M |
| Gross Profit Margin (Quarterly) | 98.37% |
| Profit Margin (Quarterly) | 4.98% |
| Earnings Yield | 10.79% |
| Operating Earnings Yield | 15.64% |
| Normalized Earnings Yield | 18.04 |